Skip to main navigation Skip to search Skip to main content

Tratamiento de las infecciones causadas por Staphylococcus aureus resistente a meticilina en América Latina.

Translated title of the contribution: [Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America].
  • Carlos M. Luna
  • , Eduardo Rodríguez-Noriega
  • , Luis Bavestrello
  • , Eduardo Gotuzzo
  • , Latinoamericano de Trabajo sobre Resistencia en Gram-Positivos Grupo Latinoamericano de Trabajo sobre Resistencia en Gram-Positivos
  • University of Buenos Aires

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The global spread of MRSA means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin America.

Translated title of the contribution[Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America].
Original languageSpanish
Pages (from-to)S94-103
JournalRevista Chilena de Infectologia
Volume27 Suppl 2
StatePublished - Aug 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of '[Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America].'. Together they form a unique fingerprint.

Cite this